<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32672457</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4804</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of medicinal chemistry</Title><ISOAbbreviation>J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs.</ArticleTitle><Pagination><StartPage>12275</StartPage><EndPage>12289</EndPage><MedlinePgn>12275-12289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.0c00510</ELocationID><Abstract><AbstractText>The RNA interference (RNAi) process encompasses the cellular mechanisms by which short-noncoding RNAs posttranscriptionally modulate gene expression. First discovered in 1998, today RNAi represents the foundation underlying complex biological mechanisms that are dysregulated in many diseases. MicroRNAs are effector molecules of gene silencing in RNAi, and their modulation can lead to a wide response in cells. Enoxacin was reported as the first and unique small-molecule enhancer of microRNA (SMER) maturation. Herein, the biological activity of enoxacin as SMER is discussed to shed light on its innovative mode of action, its potential in treating different diseases, and the feasibility of using enoxacin as a chemical template for inspiring medicinal chemists. We debate its mechanism of action at the molecular level and the possible impact on future ligand and/or structure-guided chemical optimizations, as well as opportunities and drawbacks associated with the development of quinolones such as SMERs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Felicetti</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9369-8564</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, 06123 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchetti</LastName><ForeName>Violetta</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-8558-7004</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, 06123 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfroni</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0207-3927</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, 06123 Perugia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Chem</MedlineTA><NlmUniqueID>9716531</NlmUniqueID><ISSNLinking>0022-2623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>136628-24-5</RegistryNumber><NameOfSubstance UI="C068106">trans-activation responsive RNA-binding protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>325OGW249P</RegistryNumber><NameOfSubstance UI="D015365">Enoxacin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015365" MajorTopicYN="N">Enoxacin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012323" MajorTopicYN="N">RNA Processing, Post-Transcriptional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32672457</ArticleId><ArticleId IdType="pmc">PMC8009507</ArticleId><ArticleId IdType="doi">10.1021/acs.jmedchem.0c00510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee R. C.; Feinbaum R. L.; Ambros V. The C. Elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14. Cell 1993, 75, 843&#x2013;854. 10.1016/0092-8674(93)90529-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90529-Y</ArticleId><ArticleId IdType="pubmed">8252621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman B.; Ha I.; Ruvkun G. Posttranscriptional Regulation of the Heterochronic Gene Lin-14 by Lin-4 Mediates Temporal Pattern Formation in C. Elegans. Cell 1993, 75, 855&#x2013;862. 10.1016/0092-8674(93)90530-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90530-4</ArticleId><ArticleId IdType="pubmed">8252622</ArticleId></ArticleIdList></Reference><Reference><Citation>Fire A.; Xu S.; Montgomery M. K.; Kostas S. A.; Driver S. E.; Mello C. C. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans. Nature 1998, 391, 806&#x2013;811. 10.1038/35888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35888</ArticleId><ArticleId IdType="pubmed">9486653</ArticleId></ArticleIdList></Reference><Reference><Citation>The Nobel Prize in
Physiology or Medicine 2006 -
NobelPrize.org, https://www.nobelprize.org/prizes/medicine/2006/summary/ (accessed 2019-11-04).</Citation></Reference><Reference><Citation>Ha M.; Kim V. N. Regulation of MicroRNA Biogenesis. Nat. Rev. Mol. Cell Biol. 2014, 15, 509&#x2013;524. 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatignol A.; Buckler-White A.; Berkhout B. E. N.; Jeang K. T. Characterization of a Human TAR RNA-Binding Protein That Activates the HIV-1 LTR. Science 1991, 251, 1597&#x2013;1600. 10.1126/science.2011739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2011739</ArticleId><ArticleId IdType="pubmed">2011739</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveto S.; Mancino M.; Manfrini N.; Biffo S. Role of MicroRNAs in Translation Regulation and Cancer. World J. Biol. Chem. 2017, 8, 45.10.4331/wjbc.v8.i1.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.4331/wjbc.v8.i1.45</ArticleId><ArticleId IdType="pmc">PMC5329714</ArticleId><ArticleId IdType="pubmed">28289518</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Leva G.; Garofalo M.; Croce C. M. MicroRNAs in Cancer. Annu. Rev. Pathol.: Mech. Dis. 2014, 9, 287&#x2013;314. 10.1146/annurev-pathol-012513-104715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-012513-104715</ArticleId><ArticleId IdType="pmc">PMC4009396</ArticleId><ArticleId IdType="pubmed">24079833</ArticleId></ArticleIdList></Reference><Reference><Citation>Esquela-Kerscher A.; Slack F. J. Oncomirs -MicroRNAs with a Role in Cancer. Nat. Rev. Cancer 2006, 6, 259&#x2013;269. 10.1038/nrc1840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1840</ArticleId><ArticleId IdType="pubmed">16557279</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;fekci K. U.; Oner M. G.; Meuwissen R. L. J.; Gen&#xe7; S. The Role of MicroRNAs in Human Diseases. Methods Mol. Biol. 2014, 1107, 33&#x2013;50. 10.1007/978-1-62703-748-8_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-748-8_3</ArticleId><ArticleId IdType="pubmed">24272430</ArticleId></ArticleIdList></Reference><Reference><Citation>Setten R. L.; Rossi J. J.; Han S. The Current State and Future Directions of RNAi-Based Therapeutics. Nat. Rev. Drug Discovery 2019, 18, 421&#x2013;446. 10.1038/s41573-019-0017-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0017-4</ArticleId><ArticleId IdType="pubmed">30846871</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA Approves First-of-its Kind Targeted
RNA-based Therapy to Treat
a Rare Disease | FDA, https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-targeted-rna-based-therapy-treat-rare-disease (accessed 2019-11-04).</Citation></Reference><Reference><Citation>Zhang S.; Chen L.; Jung E. J.; Calin G. A. Targeting MicroRNAs with Small Molecules: From Dream to Reality. Clin. Pharmacol. Ther. 2010, 87, 754&#x2013;758. 10.1038/clpt.2010.46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2010.46</ArticleId><ArticleId IdType="pmc">PMC3902962</ArticleId><ArticleId IdType="pubmed">20428111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumireddy K.; Young D. D.; Xiong X.; Hogenesch J. B.; Huang Q.; Deiters A. Small-Molecule Inhibitors of MicroRNA MiR-21 Function. Angew. Chem., Int. Ed. 2008, 47, 7482&#x2013;7484. 10.1002/anie.200801555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200801555</ArticleId><ArticleId IdType="pmc">PMC3428715</ArticleId><ArticleId IdType="pubmed">18712719</ArticleId></ArticleIdList></Reference><Reference><Citation>Monroig P. D. C.; Chen L.; Zhang S.; Calin G. A. Small Molecule Compounds Targeting MiRNAs for Cancer Therapy. Adv. Drug Delivery Rev. 2015, 81, 104&#x2013;116. 10.1016/j.addr.2014.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2014.09.002</ArticleId><ArticleId IdType="pmc">PMC4461213</ArticleId><ArticleId IdType="pubmed">25239236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S.; Gregory R. I. MicroRNA Biogenesis Pathways in Cancer. Nat. Rev. Cancer 2015, 15, 321&#x2013;333. 10.1038/nrc3932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3932</ArticleId><ArticleId IdType="pmc">PMC4859809</ArticleId><ArticleId IdType="pubmed">25998712</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S.; Chapnik E.; Sztainberg Y.; Eilam R.; Zwang R.; Gershoni N.; McGlinn E.; Heiser P. W.; Wills A. M.; Wirguin I.; Rubin L. L.; Misawa H.; Tabin C. J.; Brown R.; Chen A.; Hornstein E. MiRNA Malfunction Causes Spinal Motor Neuron Disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 13111&#x2013;13116. 10.1073/pnas.1006151107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006151107</ArticleId><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan G.; Li Y.; Zhang J.; Li W.; Szulwach K. E.; Duan R.; Faghihi M. A.; Khalil A. M.; Lu L.; Paroo Z.; Chan A. W. S.; Shi Z.; Liu Q.; Wahlestedt C.; He C.; Jin P. A Small Molecule Enhances RNA Interference and Promotes MicroRNA Processing. Nat. Biotechnol. 2008, 26, 933&#x2013;940. 10.1038/nbt.1481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1481</ArticleId><ArticleId IdType="pmc">PMC2831467</ArticleId><ArticleId IdType="pubmed">18641635</ArticleId></ArticleIdList></Reference><Reference><Citation>Abell N. S.; Mercado M.; Ca&#xf1;eque T.; Rodriguez R.; Xhemalce B. Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells. J. Am. Chem. Soc. 2017, 139, 1400&#x2013;1403. 10.1021/jacs.6b11751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.6b11751</ArticleId><ArticleId IdType="pubmed">28094937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashiro H.; Siomi M. C. PIWI-Interacting RNA in Drosophila: Biogenesis, Transposon Regulation, and Beyond. Chem. Rev. 2018, 118, 4404&#x2013;4421. 10.1021/acs.chemrev.7b00393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.7b00393</ArticleId><ArticleId IdType="pubmed">29281264</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.; Wang W. J.; Li Z. W.; Wang X. Z. Downregulation of Piwil3 Suppresses Cell Proliferation, Migration and Invasion in Gastric Cancer. Cancer Biomarkers 2017, 20, 499&#x2013;509. 10.3233/CBM-170324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CBM-170324</ArticleId><ArticleId IdType="pubmed">28869440</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L.; Yu C.; Gao H.; Li Y. Argonaute Proteins: Potential Biomarkers for Human Colon Cancer. BMC Cancer 2010, 10, 38.10.1186/1471-2407-10-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-10-38</ArticleId><ArticleId IdType="pmc">PMC2843668</ArticleId><ArticleId IdType="pubmed">20146808</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossiello F.; Aguado J.; Sepe S.; Iannelli F.; Nguyen Q.; Pitchiaya S.; Carninci P.; d&#x2019;Adda di Fagagna F. DNA Damage Response Inhibition at Dysfunctional Telomeres by Modulation of Telomeric DNA Damage Response RNAs. Nat. Commun. 2017, 8, 15344.10.1038/ncomms13980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13980</ArticleId><ArticleId IdType="pmc">PMC5399297</ArticleId><ArticleId IdType="pubmed">28406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelini F.; Pitchiaya S.; Vitelli V.; Sharma S.; Gioia U.; Pessina F.; Cabrini M.; Wang Y.; Capozzo I.; Iannelli F.; Matti V.; Francia S.; Shivashankar G. V.; Walter N. G.; Di Fagagna F. D. A. Damage-Induced LncRNAs Control the DNA Damage Response through Interaction with DDRNAs at Individual Double-Strand Breaks. Nat. Cell Biol. 2017, 19, 1400&#x2013;1411. 10.1038/ncb3643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3643</ArticleId><ArticleId IdType="pmc">PMC5714282</ArticleId><ArticleId IdType="pubmed">29180822</ArticleId></ArticleIdList></Reference><Reference><Citation>Burger K.; Schlackow M.; Potts M.; Hester S.; Mohammed S.; Gullerova M. Nuclear Phosphorylated Dicer Processes Double-Stranded RNA in Response to DNA Damage. J. Cell Biol. 2017, 216, 2373&#x2013;2389. 10.1083/jcb.201612131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201612131</ArticleId><ArticleId IdType="pmc">PMC5551710</ArticleId><ArticleId IdType="pubmed">28642363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioia U.; Francia S.; Cabrini M.; Brambillasca S.; Michelini F.; Jones-Weinert C. W.; d&#x2019;Adda di Fagagna F. Pharmacological Boost of DNA Damage Response and Repair by Enhanced Biogenesis of DNA Damage Response RNAs. Sci. Rep. 2019, 9, 6460.10.1038/s41598-019-42892-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42892-6</ArticleId><ArticleId IdType="pmc">PMC6478851</ArticleId><ArticleId IdType="pubmed">31015566</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;termier M.; Bertrand P.; Lopez B. S. Is Non-Homologous End-Joining Really an Inherently Error-Prone Process?. PLoS Genet. 2014, 10, e100408610.1371/journal.pgen.1004086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004086</ArticleId><ArticleId IdType="pmc">PMC3894167</ArticleId><ArticleId IdType="pubmed">24453986</ArticleId></ArticleIdList></Reference><Reference><Citation>Monroig P. del C.; Calin G. A. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities. Curr. Pathobiol. Rep. 2013, 1, 43&#x2013;52. 10.1007/s40139-013-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40139-013-0008-9</ArticleId><ArticleId IdType="pmc">PMC3600114</ArticleId><ArticleId IdType="pubmed">23515489</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzon R.; Marcucci G.; Croce C. M. Targeting MicroRNAs in Cancer: Rationale, Strategies and Challenges. Nat. Rev. Drug Discovery 2010, 9, 775&#x2013;789. 10.1038/nrd3179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3179</ArticleId><ArticleId IdType="pmc">PMC3904431</ArticleId><ArticleId IdType="pubmed">20885409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecot C. V.; Calin G. A.; Coleman R. L.; Lopez-Berestein G.; Sood A. K. RNA Interference in the Clinic: Challenges and Future Directions. Nat. Rev. Cancer 2011, 11, 59&#x2013;67. 10.1038/nrc2966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2966</ArticleId><ArticleId IdType="pmc">PMC3199132</ArticleId><ArticleId IdType="pubmed">21160526</ArticleId></ArticleIdList></Reference><Reference><Citation>Karube Y.; Tanaka H.; Osada H.; Tomida S.; Tatematsu Y.; Yanagisawa K.; Yatabe Y.; Takamizawa J.; Miyoshi S.; Mitsudomi T.; Takahashi T. Reduced Expression of Dicer Associated with Poor Prognosis in Lung Cancer Patients. Cancer Sci. 2005, 96, 111&#x2013;115. 10.1111/j.1349-7006.2005.00015.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1349-7006.2005.00015.x</ArticleId><ArticleId IdType="pubmed">15723655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R.-J.; Lin Y.-C.; Chen J.; Kuo H.-H.; Chen Y.-Y.; Diccianni M. B.; London W. B.; Chang C.-H.; Yu A. L. MicroRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma. Cancer Res. 2010, 70, 7841&#x2013;7850. 10.1158/0008-5472.CAN-10-0970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-0970</ArticleId><ArticleId IdType="pmc">PMC4095771</ArticleId><ArticleId IdType="pubmed">20805302</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo S.; Villanueva A.; Moutinho C.; Davalos V.; Spizzo R.; Ivan C.; Rossi S.; Setien F.; Casanovas O.; Simo-Riudalbas L.; Carmona J.; Carrere J.; Vidal A.; Aytes A.; Puertas S.; Ropero S.; Kalluri R.; Croce C. M.; Calin G. A.; Esteller M. Small Molecule Enoxacin Is a Cancer-Specific Growth Inhibitor That Acts by Enhancing TAR RNA-Binding Protein 2-Mediated MicroRNA Processing. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 4394&#x2013;4399. 10.1073/pnas.1014720108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014720108</ArticleId><ArticleId IdType="pmc">PMC3060242</ArticleId><ArticleId IdType="pubmed">21368194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa E. J.; Gra&#xe7;a I.; Baptista T.; Vieira F. Q.; Palmeira C.; Henrique R.; Jer&#xf3;nimo C. Enoxacin Inhibits Growth of Prostate Cancer Cells and Effectively Restores MicroRNA Processing. Epigenetics 2013, 8, 548&#x2013;558. 10.4161/epi.24519.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.24519</ArticleId><ArticleId IdType="pmc">PMC3741225</ArticleId><ArticleId IdType="pubmed">23644875</ArticleId></ArticleIdList></Reference><Reference><Citation>Valianatos G.; Valcikova B.; Growkova K.; Verlande A.; Mlcochova J.; Radova L.; Stetkova M.; Vyhnakova M.; Slaby O.; Uldrijan S. A Small Molecule Drug Promoting MiRNA Processing Induces Alternative Splicing of MdmX Transcript and Rescues P53 Activity in Human Cancer Cells Overexpressing MdmX Protein. PLoS One 2017, 12, e018580110.1371/journal.pone.0185801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185801</ArticleId><ArticleId IdType="pmc">PMC5626491</ArticleId><ArticleId IdType="pubmed">28973015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Moya J.; Wert-Lamas L.; Riesco-Eizaguirre G.; Santisteban P. Impaired MicroRNA Processing by DICER1 Downregulation Endows Thyroid Cancer with Increased Aggressiveness. Oncogene 2019, 38, 5486&#x2013;5499. 10.1038/s41388-019-0804-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-019-0804-8</ArticleId><ArticleId IdType="pmc">PMC6755984</ArticleId><ArticleId IdType="pubmed">30967628</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro E. J.; Zuo J.; Ostrov D. A.; Catalfamo D.; Bradaschia-Correa V.; Arana-Chavez V.; Caridad A. R.; Neubert J. K.; Wronski T. J.; Wallet S. M.; Holliday L. S. Enoxacin Directly Inhibits Osteoclastogenesis without Inducing Apoptosis. J. Biol. Chem. 2012, 287, 17894&#x2013;17904. 10.1074/jbc.M111.280511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.280511</ArticleId><ArticleId IdType="pmc">PMC3366803</ArticleId><ArticleId IdType="pubmed">22474295</ArticleId></ArticleIdList></Reference><Reference><Citation>Vracar T. C.; Zuo J.; Park J. S.; Azer D.; Mikhael C.; Holliday S. A.; Holsey D.; Han G.; VonMoss L.; Neubert J. K.; Rody W. J.; Chan E. K. L.; Holliday L. S. Enoxacin and Bis-Enoxacin Stimulate 4T1Murine Breast Cancer Cells to Release Extracellular Vesicles that Inhibit Osteoclastogenesis. Sci. Rep. 2018, 8, 16182.10.1038/s41598-018-34698-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34698-9</ArticleId><ArticleId IdType="pmc">PMC6212457</ArticleId><ArticleId IdType="pubmed">30385810</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Pol E.; B&#xf6;ing A. N.; Gool E. L.; Nieuwland R. Recent Developments in the Nomenclature, Presence, Isolation, Detection and Clinical Impact of Extracellular Vesicles. J. Thromb. Haemostasis 2016, 14, 48&#x2013;56. 10.1111/jth.13190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13190</ArticleId><ArticleId IdType="pubmed">26564379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornaz-Buros S.; Riggi N.; Devito C.; Sarre A.; Letovanec I.; Provero P.; Stamenkovic I. Targeting Cancer Stem-Like Cells as an Approach to Defeating Cellular Heterogeneity in Ewing Sarcoma. Cancer Res. 2014, 74, 6610&#x2013;6622. 10.1158/0008-5472.CAN-14-1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-14-1106</ArticleId><ArticleId IdType="pubmed">25261238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O.; Al-Chalabi A.; Chio A.; Corr E. M.; Logroscino G.; Robberecht W.; Shaw P. J.; Simmons Z.; van den Berg L. H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Prim. 2017, 3, 17071.10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A.; Hornstein E. MiRNAs at the Interface of Cellular Stress and Disease. EMBO J. 2014, 33, 1428&#x2013;1437. 10.15252/embj.201488142.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201488142</ArticleId><ArticleId IdType="pmc">PMC4194087</ArticleId><ArticleId IdType="pubmed">24867813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori M. A.; Raghavan P.; Thomou T.; Boucher J.; Robida-Stubbs S.; MacOtela Y.; Russell S. J.; Kirkland J. L.; Blackwell T. K.; Kahn C. R. Role of MicroRNA Processing in Adipose Tissue in Stress Defense and Longevity. Cell Metab. 2012, 16, 336&#x2013;347. 10.1016/j.cmet.2012.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.07.017</ArticleId><ArticleId IdType="pmc">PMC3461823</ArticleId><ArticleId IdType="pubmed">22958919</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A.; Eitan C.; Liou L.-L.; Libby R. T.; Rivkin N.; Magen I.; Reichenstein I.; Oppenheim H.; Eilam R.; Silvestroni A.; Alajajian B.; Ben-Dov I. Z.; Aebischer J.; Savidor A.; Levin Y.; Sons R.; Hammond S. M.; Ravits J. M.; Mo ller T.; Hornstein E. Dysregulated MiRNA Biogenesis Downstream of Cellular Stress and ALS-Causing Mutations: A New Mechanism for ALS. EMBO J. 2015, 34, 2633&#x2013;2651. 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Moya J.; Wert-Lamas L.; Santisteban P. MicroRNA-146b Promotes PI3K/AKT Pathway Hyperactivation and Thyroid Cancer Progression by Targeting PTEN. Oncogene 2018, 37, 3369&#x2013;3383. 10.1038/s41388-017-0088-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-017-0088-9</ArticleId><ArticleId IdType="pubmed">29353884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti M.; Filosa G.; Melzi V.; Calandriello L.; Dioni L.; Bollati V.; Bresolin N.; Comi G. P.; Barabino S.; Nizzardo M.; Corti S. MicroRNA Expression Analysis Identifies a Subset of Downregulated MiRNAs in ALS Motor Neuron Progenitors. Sci. Rep. 2018, 8, 10105.10.1038/s41598-018-28366-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28366-1</ArticleId><ArticleId IdType="pmc">PMC6031650</ArticleId><ArticleId IdType="pubmed">29973608</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T. A.; Kukharsky M. S.; An H.; Dimasi P.; Alexeeva S.; Shabir O.; Heath P. R.; Buchman V. L. Protective Paraspeckle Hyper-Assembly Downstream of TDP-43 Loss of Function in Amyotrophic Lateral Sclerosis. Mol. Neurodegener. 2018, 13, 30.10.1186/s13024-018-0263-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0263-7</ArticleId><ArticleId IdType="pmc">PMC5984788</ArticleId><ArticleId IdType="pubmed">29859124</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox A. H.; Lamond A. I. Paraspeckles. Cold Spring Harbor Perspect. Biol. 2010, 2, a00068710.1101/cshperspect.a000687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000687</ArticleId><ArticleId IdType="pmc">PMC2890200</ArticleId><ArticleId IdType="pubmed">20573717</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y.; Mieda-Sato A. TDP-43 Promotes MicroRNA Biogenesis as a Component of the Drosha and Dicer Complexes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 3347&#x2013;3352. 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.; Shao C.; Wu Q.-J.; Chen G.; Zhou J.; Yang B.; Li H.; Gou L.-T.; Zhang Y.; Wang Y.; Yeo G. W.; Zhou Y.; Fu X.-D. NEAT1 Scaffolds RNA-Binding Proteins and the Microprocessor to Globally Enhance Pri-MiRNA Processing. Nat. Struct. Mol. Biol. 2017, 24, 816&#x2013;824. 10.1038/nsmb.3455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3455</ArticleId><ArticleId IdType="pmc">PMC5766049</ArticleId><ArticleId IdType="pubmed">28846091</ArticleId></ArticleIdList></Reference><Reference><Citation>EU/3/15/1459 | European Medicines Agency, https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3151459 (accessed 2019-12-17).</Citation></Reference><Reference><Citation>Smalheiser N. R.; Zhang H.; Dwivedi Y. Enoxacin Elevates MicroRNA Levels in Rat Frontal Cortex and Prevents Learned Helplessness. Front. Psychiatry 2014, 5, 6.10.3389/fpsyt.2014.00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2014.00006</ArticleId><ArticleId IdType="pmc">PMC3918929</ArticleId><ArticleId IdType="pubmed">24575053</ArticleId></ArticleIdList></Reference><Reference><Citation>Smalheiser N. R.; Lugli G.; Rizavi H. S.; Torvik V. I.; Turecki G.; Dwivedi Y. MicroRNA Expression Is Down-Regulated and Reorganized in Prefrontal Cortex of Depressed Suicide Subjects. PLoS One 2012, 7, e3320110.1371/journal.pone.0033201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033201</ArticleId><ArticleId IdType="pmc">PMC3302855</ArticleId><ArticleId IdType="pubmed">22427989</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheld W. M. Quinolone Therapy for Infections of the Central Nervous System. Clin. Infect. Dis. 1989, 11, 1194&#x2013;1202. 10.1093/clinids/11.Supplement_5.S1194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/11.Supplement_5.S1194</ArticleId><ArticleId IdType="pubmed">2672249</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y. P.; Qiu Y.; Zhang B.; Chen G.; Chen Q.; Wang M.; Mo F.; Xu J.; Wu J.; Zhang R. R.; Cheng M. L.; Zhang N. N.; Lyu B.; Zhu W. L.; Wu M. H.; Ye Q.; Zhang D.; Man J. H.; Li X. F.; Cui J.; Xu Z.; Hu B.; Zhou X.; Qin C. F. Zika Virus Infection Induces RNAi-Mediated Antiviral Immunity in Human Neural Progenitors and Brain Organoids. Cell Res. 2019, 29, 265&#x2013;273. 10.1038/s41422-019-0152-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0152-9</ArticleId><ArticleId IdType="pmc">PMC6461993</ArticleId><ArticleId IdType="pubmed">30814679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z.; Song H.; Ming G. L. How Does Zika Virus Cause Microcephaly?. Genes Dev. 2017, 31, 849&#x2013;861. 10.1101/gad.298216.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.298216.117</ArticleId><ArticleId IdType="pmc">PMC5458753</ArticleId><ArticleId IdType="pubmed">28566536</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H.; Hammack C.; Ogden S. C.; Wen Z.; Qian X.; Li Y.; Yao B.; Shin J.; Zhang F.; Lee E. M.; Christian K. M.; Didier R. A.; Jin P.; Song H.; Ming G. L. Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth. Cell Stem Cell 2016, 18, 587&#x2013;590. 10.1016/j.stem.2016.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2016.02.016</ArticleId><ArticleId IdType="pmc">PMC5299540</ArticleId><ArticleId IdType="pubmed">26952870</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S.; Sato V. N.; De-Souza E. A.; Ferraz R. C.; Camara H.; Pinca A. P. F.; Mazzotti D. R.; Lovci M. T.; Tonon G.; Lopes-Ramos C. M.; Parmigiani R. B.; Wurtele M.; Massirer K. B.; Mori M. A. Enoxacin Extends Lifespan of C. Elegans by Inhibiting MiR-34&#x2013;5p and Promoting Mitohormesis. Redox Biol. 2018, 18, 84&#x2013;92. 10.1016/j.redox.2018.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.06.006</ArticleId><ArticleId IdType="pmc">PMC6037660</ArticleId><ArticleId IdType="pubmed">29986212</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Vikos T.; Slack F. J. MicroRNAs and Their Roles in Aging. J. Cell Sci. 2012, 125, 7&#x2013;17. 10.1242/jcs.099200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.099200</ArticleId><ArticleId IdType="pmc">PMC3269020</ArticleId><ArticleId IdType="pubmed">22294612</ArticleId></ArticleIdList></Reference><Reference><Citation>Warf M. B.; Shepherd B. a.; Johnson W. E.; Bass B. L. Effects of ADARs on Small RNA Processing Pathways in C. elegans. Genome Res. 2012, 22, 1488&#x2013;1498. 10.1101/gr.134841.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.134841.111</ArticleId><ArticleId IdType="pmc">PMC3409262</ArticleId><ArticleId IdType="pubmed">22673872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.; Chendrimada T. P.; Wang Q.; Higuchi M.; Seeburg P. H.; Shiekhattar R.; Nishikura K. Modulation of MicroRNA Processing and Expression through RNA Editing by ADAR Deaminases. Nat. Struct. Mol. Biol. 2006, 13, 13&#x2013;21. 10.1038/nsmb1041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1041</ArticleId><ArticleId IdType="pmc">PMC2950615</ArticleId><ArticleId IdType="pubmed">16369484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.; Tian Y.; Wang M.; Wang M.; Sun G. B.; Sun X. B. Advanced Activity-Based Protein Profiling Application Strategies for Drug Development. Front. Pharmacol. 2018, 9, 353.10.3389/fphar.2018.00353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00353</ArticleId><ArticleId IdType="pmc">PMC5900428</ArticleId><ArticleId IdType="pubmed">29686618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota H.; Sakurai M.; Gupta R.; Valente L.; Wulff B. E.; Ariyoshi K.; Iizasa H.; Davuluri R. V.; Nishikura K. ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing. Cell 2013, 153, 575&#x2013;589. 10.1016/j.cell.2013.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.03.024</ArticleId><ArticleId IdType="pmc">PMC3651894</ArticleId><ArticleId IdType="pubmed">23622242</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.; Wang J.; Cheng H.; Ke X.; Sun L.; Zhang Q. C.; Wang H. W. Cryo-EM Structure of Human Dicer and Its Complexes with a Pre-MiRNA Substrate. Cell 2018, 173, 1191&#x2013;1203. 10.1016/j.cell.2018.03.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.080</ArticleId><ArticleId IdType="pubmed">29706542</ArticleId></ArticleIdList></Reference><Reference><Citation>Fareh M.; Yeom K. H.; Haagsma A. C.; Chauhan S.; Heo I.; Joo C. TRBP Ensures Efficient Dicer Processing of Precursor MicroRNA in RNA-Crowded Environments. Nat. Commun. 2016, 7, 13694.10.1038/ncomms13694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13694</ArticleId><ArticleId IdType="pmc">PMC5155159</ArticleId><ArticleId IdType="pubmed">27934859</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah G.; Maris C.; K&#xf6;nig S. L.; Yulikov M.; Aeschimann F.; Malinowska A. L.; Mabille J.; Weiler J.; Holla A.; Hunziker J.; Meisner-Kober N.; Schuler B.; Jeschke G.; Allain F. H.-T. Structural Basis of Si-RNA Recognition by TRBP Double-Stranded RNA Binding Domains. EMBO J. 2018, 37, e9708910.15252/embj.201797089.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797089</ArticleId><ArticleId IdType="pmc">PMC5852647</ArticleId><ArticleId IdType="pubmed">29449323</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino V. G.; Sighel D.; Zucal C.; Bonomo I.; Micaelli M.; Lolli G.; Provenzani A.; Quattrone A.; Adami V. Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery. SLAS Discovery 2019, 24, 314&#x2013;331. 10.1177/2472555218818065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2472555218818065</ArticleId><ArticleId IdType="pubmed">30616427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S. RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment. J. Cancer Prev. 2017, 22, 203&#x2013;210. 10.15430/JCP.2017.22.4.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.15430/JCP.2017.22.4.203</ArticleId><ArticleId IdType="pmc">PMC5751837</ArticleId><ArticleId IdType="pubmed">29302577</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Aal M. A. A.; Abdel-Aziz S. A.; Shaykoon M. S. A.; Abuo-Rahma G. E.-D. A. Towards Anticancer Fluoroquinolones: A Review Article. Arch. Pharm. (Weinheim, Ger.) 2019, 352, e180037610.1002/ardp.201800376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ardp.201800376</ArticleId><ArticleId IdType="pubmed">31215674</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F.; Zhang X.; Wang T.; Xiao J. Quinolone Hybrids and Their Anti-Cancer Activities: An Overview. Eur. J. Med. Chem. 2019, 165, 59&#x2013;79. 10.1016/j.ejmech.2019.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.01.017</ArticleId><ArticleId IdType="pubmed">30660827</ArticleId></ArticleIdList></Reference><Reference><Citation>Suaifan G. A. R. Y.; Mohammed A. A. M. Fluoroquinolones Structural and Medicinal Developments (2013&#x2013;2018): Where Are We Now?. Bioorg. Med. Chem. 2019, 27, 3005&#x2013;3060. 10.1016/j.bmc.2019.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2019.05.038</ArticleId><ArticleId IdType="pubmed">31182257</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav V.; Talwar P. Repositioning of Fluoroquinolones from Antibiotic to Anti-Cancer Agents: An Underestimated Truth. Biomed. Pharmacother. 2019, 111, 934&#x2013;946. 10.1016/j.biopha.2018.12.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.12.119</ArticleId><ArticleId IdType="pubmed">30841473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuzuki Y.; Tomita K.; Shibamori K.; Sato Y.; Kashimoto S.; Chiba K. Synthesis and Structure-Activity Relationships of Novel 7-Substituted 1,4-Dihydro-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acids as Antitumor Agents. Part 2. J. Med. Chem. 2004, 47, 2097&#x2013;2109. 10.1021/jm0304966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0304966</ArticleId><ArticleId IdType="pubmed">15056007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezelarab H. A. A.; Abbas S. H.; Hassan H. A.; Abuo-Rahma G. E. D. A. Recent Updates of Fluoroquinolones as Antibacterial Agents. Arch. Pharm. (Weinheim, Ger.) 2018, 351, e180014110.1002/ardp.201800141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ardp.201800141</ArticleId><ArticleId IdType="pubmed">30048015</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisacchi G.; Hale M. A &#x201c;Double-Edged&#x201d; Scaffold: Antitumor Power within the Antibacterial Quinolone. Curr. Med. Chem. 2016, 23, 520&#x2013;577. 10.2174/0929867323666151223095839.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666151223095839</ArticleId><ArticleId IdType="pmc">PMC4997924</ArticleId><ArticleId IdType="pubmed">26695512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf R.; Eberl R.; Dunky A.; Mertz N.; Chang T.; Goulet J. R.; Latts J. The Clinical Pharmacokinetics and Tolerance of Enoxacin in Healthy Volunteers. J. Antimicrob. Chemother. 1984, 14, 63&#x2013;69. 10.1093/jac/14.suppl_C.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/14.suppl_C.63</ArticleId><ArticleId IdType="pubmed">6389476</ArticleId></ArticleIdList></Reference><Reference><Citation>Henwood J. M.; Monk J. P. Enoxacin. A Review of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use. Drugs 1988, 36, 32&#x2013;66. 10.2165/00003495-198836010-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-198836010-00004</ArticleId><ArticleId IdType="pubmed">3063494</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti V.; Parolin C.; Moro S.; Pecere T.; Filipponi E.; Calistri A.; Tabarrini O.; Gatto B.; Palumbo M.; Fravolini A.; Palu&#x2019; G. 6-Aminoquinolones as New Potential Anti-HIV Agents. J. Med. Chem. 2000, 43, 3799&#x2013;3802. 10.1021/jm9903390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9903390</ArticleId><ArticleId IdType="pubmed">11020296</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabarrini O.; Stevens M.; Cecchetti V.; Sabatini S.; Dell&#x2019;Uomo M.; Manfroni G.; Palumbo M.; Pannecouque C.; De Clercq E.; Fravolini A. Structure Modifications of 6-Aminoquinolones with Potent Anti-HIV Activity. J. Med. Chem. 2004, 47, 5567&#x2013;5578. 10.1021/jm049721p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm049721p</ArticleId><ArticleId IdType="pubmed">15481992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabarrini O.; Massari S.; Daelemans D.; Stevens M.; Manfroni G.; Sabatini S.; Balzarini J.; Cecchetti V.; Pannecouque C.; Fravolini A. Structure-Activity Relationship Study on Anti-HIV 6-Desfluoroquinolones. J. Med. Chem. 2008, 51, 5454&#x2013;5458. 10.1021/jm701585h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm701585h</ArticleId><ArticleId IdType="pubmed">18710207</ArticleId></ArticleIdList></Reference><Reference><Citation>Massari S.; Daelemans D.; Manfroni G.; Sabatini S.; Tabarrini O.; Pannecouque C.; Cecchetti V. Studies on Anti-HIV Quinolones: New Insights on the C-6 Position. Bioorg. Med. Chem. 2009, 17, 667&#x2013;674. 10.1016/j.bmc.2008.11.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2008.11.056</ArticleId><ArticleId IdType="pubmed">19091580</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfroni G.; Cannalire R.; Barreca M. L.; Kaushik-Basu N.; Leyssen P.; Winquist J.; Iraci N.; Manvar D.; Paeshuyse J.; Guhamazumder R.; Basu A.; Sabatini S.; Tabarrini O.; Danielson U. H.; Neyts J.; Cecchetti V. The Versatile Nature of the 6-Aminoquinolone Scaffold: Identification of Submicromolar Hepatitis C Virus NS5B Inhibitors. J. Med. Chem. 2014, 57, 1952&#x2013;1963. 10.1021/jm401362f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm401362f</ArticleId><ArticleId IdType="pmc">PMC3954902</ArticleId><ArticleId IdType="pubmed">24131104</ArticleId></ArticleIdList></Reference><Reference><Citation>Franci G.; Manfroni G.; Cannalire R.; Felicetti T.; Tabarrini O.; Salvato A.; Barreca M. L.; Altucci L.; Cecchetti V. Tumour Cell Population Growth Inhibition and Cell Death Induction of Functionalized 6-Aminoquinolone Derivatives. Cell Proliferation 2015, 48, 705&#x2013;717. 10.1111/cpr.12224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12224</ArticleId><ArticleId IdType="pmc">PMC6496377</ArticleId><ArticleId IdType="pubmed">26597381</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency . Fluoroquinolone and Quinolone Antibiotics:
PRAC Recommends New Restrictions on Use Following Review of Disabling
and Potentially Long-Lasting Side Effects. https://www.ema.europa.eu/en/news/fluoroquinolone-quinolone-antibiotics-prac-recommends-new-restrictions-use-following-review (accessed 2020-05-23).</Citation></Reference><Reference><Citation>US Food and Drug Administration . FDA Updates Warnings for Fluoroquinolone
Antibiotics on Risks of Mental Health and Low Blood Sugar Adverse
Reactions. https://www.fda.gov/news-events/press-announcements/fda-updates-warnings-fluoroquinolone-antibiotics-risks-mental-health-and-low-blood-sugar-adverse (accessed 2020-05-23).</Citation></Reference><Reference><Citation>Mallick B.; Ghosh Z.; Chakrabarti J. MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells. PLoS One 2009, 4, e783710.1371/journal.pone.0007837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007837</ArticleId><ArticleId IdType="pmc">PMC2773932</ArticleId><ArticleId IdType="pubmed">19915717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai F. W.; Stephenson K. B.; Mahony J.; Lichty B. D. Human Coronavirus OC43 Nucleocapsid Protein Binds MicroRNA 9 and Potentiates NF-KB Activation. J. Virol. 2014, 88, 54&#x2013;65. 10.1128/JVI.02678-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02678-13</ArticleId><ArticleId IdType="pmc">PMC3911702</ArticleId><ArticleId IdType="pubmed">24109243</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon-Icaza S. A.; Zeng M.; Rosas-Taraco A. G. MicroRNAs in Viral Acute Respiratory Infections: Immune Regulation, Biomarkers, Therapy, and Vaccines. ExRNA 2019, 1, 1&#x2013;7. 10.1186/s41544-018-0004-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41544-018-0004-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A.; Inchley C. S.; Marzban M.; Tavakoli-Yaraki M.; Teymoori-Rad M.; Nakstad B.; Salimi V. The Role of MicroRNAs in Respiratory Viral Infection: Friend or Foe?. Rev. Med. Virol. 2016, 26, 389&#x2013;407. 10.1002/rmv.1894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1894</ArticleId><ArticleId IdType="pmc">PMC7169129</ArticleId><ArticleId IdType="pubmed">27373545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>